doi: 10.5732/cjc.013.10038

Clinical implications of microRNAs in liver cancer stem cells

Stella Chai, Stephanie Ma

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P. R. China.

[Abstract] The prognosis of patients diagnosed with hepatocellular carcinoma (HCC) is often dismal, mainly due to late presentation, high recurrence rate, and frequent resistance to chemotherapy and radiotherapy. Accumulating evidence on the differential microRNA (miRNA) expression patterns between non-tumor and HCC tissues or between liver cancer stem cells (CSCs) and non-CSC subsets and the significant clinical implications of these differences suggest that miRNAs are a promising, non-invasive marker for the prognosis and diagnosis of the disease. This perspective article summarizes the current knowledge of miRNAs in liver CSCs and highlights the need for further investigations of the role of miRNAs in regulating liver CSC subsets for possible future clinical applications.

Chinese Journal of Cancer 2013, Volume: 32, Issue 8, Page: 419-426

[ PDF Full-text ]
[ Html full-text ](PubMed Central)
[ PubMed ]
[Google Scholar]

Cite this article

Stella Chai, Stephanie Ma. Clinical implications of microRNAs in liver cancer stem cells . Chin J Cancer. 2013, 32(8):419-426. doi:10.5732/cjc.013.10038


Export citations

EndNote